CorMedix Inc. Announces Scientific Advisory Board to

BERKELEY HEIGHTS, N.J., April 07, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...

Related Keywords

United States ,America ,Stanley Crittenden ,Defencath Neutrolin ,Matt David ,Saravanan Balamuthusamy ,Sara Bonnes ,Jonathan Waitman ,Bruce Polsky ,Liz Hurlburt ,Shannah Newman ,Division Of Internal Medicine ,College Of Ft ,Cumming School Of Medicine ,Northwell Health ,Drug Administration ,Weill Cornell Medical College ,Nasdaq ,Nephrology Associates ,Cormedix Inc ,University Of Calgary ,Long Island School Of Medicine ,Department Of Medicine ,Fresenius Medical Care ,Scientific Advisory Board ,Clinical Operations ,Advisory Board Members ,Internal Medicine ,Medical College ,Physician Nutrition Specialist ,Chief Medical Officer ,Molecular Biology ,Cumming School ,Infection Prevention ,Associate Dean ,Island School ,Medical Director ,Specialized Nutrition Support ,Weill Cornell Medical ,Fast Track ,Qualified Infectious Disease Product ,New Drug Application ,New Chemical Entity ,Complete Response Letter ,Private Securities Litigation Reform Act ,Nasdaq Crmd ,Cormedix ,Nc ,